SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing a surge in investor interest driven by recent production order wins for its Sonoma high-power test platforms, which are being integrated into critical hyperscale AI infrastructure. The community is focused on the potential for a massive commercial scale-up in the coming year, with active debates centered on whether recent contract wins represent a definitive pivot toward sustainable, high-volume growth that justifies current valuation levels.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a major focus for market participants as traders monitor its price action against broader volatility and navigate the fallout from the recent Drift Protocol exploit. The community is actively debating the network's resilience and long-term viability, with many users focusing on accumulation strategies and speculative opportunities across the ecosystem's meme coin landscape.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXY is attracting intense retail attention as traders debate the ETF's structural decay and its role as a high-volatility hedge against Middle East geopolitical instability. The community remains sharply divided between those betting on aggressive upside driven by fear-based volume and those advocating for short positions to capitalize on the instrument's long-term negative roll yield.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

Plasma ($XPL) is currently facing significant volatility and intense debate, with the community split between investors viewing it as a high-potential stablecoin infrastructure play and those labeling the project a pump-and-dump scheme. Sentiment is heavily influenced by rapid price fluctuations, concerns over token unlocks, and ongoing speculation regarding the project's long-term utility.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying following a stronger-than-expected earnings report that beat analyst estimates for adjusted earnings and provided positive revenue guidance, fueling a significant breakout. The community is actively debating whether this movement represents a fundamental trend reversal toward long-term solar adoption or if the stock remains a volatile playground for speculative options traders and short-covering activity.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render (RENDER) is trending as investors aggressively debate its long-term potential as a foundational AI compute asset, with sentiment split between those accumulating on dips and those frustrated by its recent price volatility. Community conversation is heavily focused on Render's pivotal role in decentralized AI infrastructure and expectations that upcoming industry catalysts will reignite its momentum.

USELESS

USELESS is gaining significant community traction as traders track its consolidation phase and potential for a breakout amid broader altcoin rotation. Discussion centers on its high-beta profile and the irony of its branding, with active debates split between bullish accumulation strategies and skeptical views on its meme-driven longevity.

MATH is a one stop crypto solution platform which contains MathWallet, MATH VPOS Pool, MathDEX, MATH dApp Store, MATH Staking, MATH Pay, MATH Chain, etc.

MATH

The MATH community is actively debating the token's potential for a significant breakout, fueled by its low market cap and historical patterns of sudden, sharp volatility. While some investors are expressing frustration over stagnant price action and questioning leadership, others remain optimistic that upcoming altcoin cycle trends could act as a catalyst for a sustained move upward.

Shido

Shido is generating significant buzz due to the official launch of the Nova EVM infrastructure and a successful proposal to reduce on-chain inflation, which the community sees as a catalyst for long-term token scarcity and ecosystem sustainability. Investors and developers are actively discussing the network's high-performance capabilities, including sub-second block finality and new AI-enhanced trading tools, as the platform transitions into a deeply optimized execution network.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors digest significant institutional accumulation and strategic partnerships, including a recent major defense contract and collaboration with top-tier technology firms. Community sentiment remains bullish, with many traders focusing on the company's long-term potential as an AI infrastructure leader and anticipating a breakout from its recent trading range.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The authority said it has received 43 claims from patients who believe they developed the condition known as NAION after taking Wegovy or Ozempic.</li><li>Though the agency granted compensation in four claims, it also rejected one, bringing the total number of settled cases to five.</li><li>As per the agency, not all cases automatically qualify for compensation, but instead, each claim will be assessed individually.</li></ul><p>Four patients taking Novo Nordisk’s (NVO) weight loss drugs have been granted compensation in Denmark after they developed an adverse reaction that affected their eyes.</p><p>The four claimants will receive a combined 800,000 kroner, though that figure may rise, Danish Patient Compensation <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://patienterstatningen.dk/presse-og-nyheder/nyheder/2025/nov/de-foerste-patienter-faar-erstatning-for-alvorlig-oejensygdom-efter-wegovy-og-ozempic">said</a> on Friday. If it is proved that the eye disease is to blame for the patients not being able to do their jobs to the same extent as before, they will be entitled to compensation for loss of earning capacity, the authority said.</p><h2 class="st-heading-2">Cases In Question</h2><p>The authority said it has received 43 claims from patients who believe they developed the condition known as NAION after taking Wegovy or Ozempic.</p><p>NAION, or non-arteritic anterior ischemic optic neuropathy, is a medical condition causing sudden, painless vision loss due to a lack of blood flow to the optic nerve. There is no cure for the condition, which can cause blurry or worsening vision, reduced color vision, and optic disc swelling.</p><h2 class="st-heading-2">Compensation Not Guaranteed</h2><p>Though the agency granted compensation in four claims, it also rejected one, bringing the total number of settled cases to five. According to the agency, not all cases automatically qualify for compensation; each claim will be assessed individually to determine whether compensation is warranted.</p><p>“NAION is a serious disease that causes permanent and incurable damage to vision. It is also a very complex case to assess because it is a new medicine and the patients are already in the risk group for getting NAION. Our task is to give patients a thorough and well-thought-out decision," director of Patient Compensation, Karen-Inger Bast, said. &nbsp;</p><p>The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) considers NAION to be a rare side effect of Wegovy, Ozempic, and Rybelsus.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p><a href="https://stocktwits.com/symbol/NVO">NVO shares</a> traded 1% lower on Friday morning at the time of writing. On Stocktwits, retail sentiment around NVO stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.</p><p>NVO stock is down 45% this year and by about 54% over the past 12 months.&nbsp;</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-etfs-hit-record-outflows-average-investor-now-in-the-red/cLPMoktREOm">Bitcoin ETFs Hit Record Monthly Outflows In November – Average Investor Now in the Red, Says Analyst</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. 

Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic

The four claimants will receive a combined 800,000 kroner, though that figure may rise, Danish Patient Compensation said on Friday.

Equity

The four claimants will receive a combined 800,000 kroner, though that figure may rise, Danish Patient Compensation said on Friday.


<ul class="summary-bullets"><li>The facility is part of the company’s commitment, earlier this year, to invest $23 billion in the U.S. over the next five years.&nbsp;</li><li>Novartis is now also planning two additional RLT manufacturing facilities in Florida and Texas.&nbsp;</li><li>The U.S. is one of Novartis’ priority geographies in addition to China, Germany, and Japan.</li></ul><p>Novartis (NVS) on Monday said that it has opened a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California, marking its third RLT manufacturing site in the country.</p><p>The facility is part of the company’s commitment earlier this year to invest $23 billion in the U.S. over the next five years.</p><h2 class="st-heading-2">Goals Of The New Facility</h2><p>The new facility is designed to add capacity for radioligand therapy, meeting future demand, and enhance the company’s supply chain capabilities, Novartis <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.novartis.com/news/media-releases/novartis-opens-new-radioligand-therapy-manufacturing-facility-california-part-23b-us-expansion-plan">stated.</a></p><p>Radioligand therapy is a targeted cancer treatment that combines a radioactive substance (radioisotope) with a cancer-targeting molecule (ligand). It is aimed at reducing damage to surrounding cells.</p><p>However, each RLT dose is custom-made and time-sensitive, making proximity to treatment centers and transit hubs necessary for patient access. The new site will ensure access to patients across the western U.S., Alaska, and Hawaii, Novartis said.</p><p>Commercial manufacturing at the facility is expected to begin once approval is granted by the U.S. Food and Drug Administration, the company added.</p><h2 class="st-heading-2">Future Expansion Plans</h2><p>Novartis is now also planning two additional RLT manufacturing facilities in Florida and Texas. &nbsp;</p><p>In addition, it is also eyeing expansion of existing sites in Durham, North Carolina, Indianapolis, Indiana, and Millburn, New Jersey, and expects to establish a second global research and development hub in the U.S. in San Diego, California.</p><p>The U.S. is one of Novartis’ priority geographies, alongside China, Germany, and Japan.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NVS">NVS stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.</p><p>NVS stock is up 31% this year and approximately 20% over the past 12 months.&nbsp;</p><p>Also See: <a href="https://stocktwits.com/news-articles/markets/equity/grab-holdings-to-take-equity-interest-in-remote-driving-tech-startup/cLPcKrSRE2c">Grab Deepens Autonomous Mobility Push With $60 Million Investment In Vay</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

In this photo illustration, the Novartis company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence

Commercial manufacturing at the facility is expected to begin once approval is granted by the U.S. Food and Drug Administration, the company added.

GMO ETF Trust - GMO International Quality ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

QLTI
QLT Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest QLTI News

QLTIQLT Inc.